Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-46.12	-92.53	171.71
Graham Fair Price	-51.13	2.09	4.28
PEG	8770.46	0.11	< 0.005
Price/Book	-18.29	0.48	0.59
Price/Cash Flow	-169.02	-287.39	-106.83
Prices/Earnings	-237.88	-8.38	-2.48
Price/Sales	-11.90	9.83	11.16
Price/FCF	-169.02	-287.39	-106.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-87.85	0.05	0.37
Operating Margin	78.49	-0.29	-1.34
ROA	76.36	< 0.005	-0.02
ROE	-0.06	-0.01	75.82
ROIC	-0.03	< 0.005	76.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	62.63
Dividends QOQ	1.65	-0.79	-51.91
EBIT QOQ	-26.61	0.80	-96.98
EPS QOQ	-19.95	0.76	-96.19
FCF QOQ	-2.06	0.70	-66.00
Revenue QOQ	< 0.005	-0.09	-1365.78
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	174.80	138.76	-20.62
Days Sales Outstanding (DSO)	1675.73	1880.60	12.23
Inventory Turnover	0.51	0.65	25.98
Debt/Capitalization	0.49	0.50	0.60
Quick Ratio	0.84	0.84	-0.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.70	3.68	-0.63
Cash	1.44	1.44	0.62
Capex	-0.02	< 0.005	69.82
Free Cash Flow	-0.02	< 0.005	69.82
Revenue	0.20	0.18	-7.84
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.90	0.90	0.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	84.08	-50.19	-40.30
Naive Interpretation	Member

06 - Financial Health · Bad

Rating